In other countries
The same active substances on other registers, the same brand first.
- Atrolak Prolong 300 MG Comprimidos de Liberacion Prolongada EfgSpain · 345,45 mg · comprimido de liberación prolongada · Accord Healthcare S.L.U.Same substance
- Atrolak Prolong 400MG Comprimidos de Liberacion Prolongada EfgSpain · 460,6 mg · comprimido de liberación prolongada · Accord Healthcare S.L.U.Same substance
- PSICOTRIC 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFGSpain · 115,132 mg · comprimido recubierto con película · Neuraxpharm Spain S.L.U.Same substance
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions · Added 12 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Hemifumarato quetiapina
- Register
- Brazil (Anvisa)
- Status
- Authorised
- Status in the register
- Ativo
- Authorised
- 11 Jul 2016
- Registration
- 100431191
- Marketing authorisation holder
- Eurofarma Laboratorios S.A.
- Procedure
- Registered